Valuation: Lonza Group AG

Market Cap 40.93B 50.73B 44.37B 37.8B 71.73B 4,838B 72.93B 489B 192B 2,383B 190B 186B 8,194B P/E 2026 *
35.4x
P/E 2027 * 29.1x
Enterprise Value 44.14B 54.71B 47.86B 40.77B 77.36B 5,218B 78.66B 527B 207B 2,571B 205B 201B 8,838B EV / Sales 2026 *
6.18x
EV / Sales 2027 * 5.49x
Free-Float
99.36%
Yield 2026 *
0.93%
Yield 2027 * 1.06%
1 day+0.58%
1 week+2.06%
Current month+7.37%
1 month+19.11%
3 months+13.79%
6 months+5.85%
Current year+8.96%
1 week 566.2
Extreme 566.2
591
1 month 484
Extreme 484
591
Current year 454.6
Extreme 454.6
591
1 year 454.6
Extreme 454.6
594.8
3 years 308.6
Extreme 308.6
616
5 years 308.6
Extreme 308.6
785.4
10 years 156.2
Extreme 156.2
785.4
Manager TitleAgeSince
Chief Executive Officer 54 01/07/2024
Director of Finance/CFO 54 01/12/2021
Chief Operating Officer - 01/10/2025
Director TitleAgeSince
Director/Board Member 67 26/04/2016
Director/Board Member 66 04/05/2018
Director/Board Member 60 05/05/2022
Date Insider Type Main position Quantity % Market Cap.
08/05Buy 460 0.0007%
08/05Buy 618 0.0009%
11/03Buy 60 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.58%+2.06%+3.90%+10.40% 50.73B
-2.22%-1.25%+391.53%+591.38% 39.73B
-0.54%+0.39%+27.67%-3.89% 34.69B
-1.36%+0.35%+19.34%+58.83% 33.21B
+1.21%-4.58%+3.00%+37.03% 26.76B
-1.81%-1.48% - - 16.8B
+0.51%-3.47%+66.38%+125.61% 15.37B
+0.23%-0.58%+13.80%+19.56% 13.78B
-0.62%-3.09%+11.43%-29.93% 12.85B
+0.24%-8.96%+1,628.55%+669.09% 12.11B
Average -0.38%-1.64%+240.62%+164.23% 25.6B
Weighted average by Cap. -0.45%-0.64%+161.01%+153.63%

Financials

2026 *2027 *
Net sales 7.14B 8.85B 7.74B 6.59B 12.51B 844B 12.72B 85.29B 33.49B 416B 33.22B 32.5B 1,429B 7.99B 9.9B 8.66B 7.38B 14B 945B 14.24B 95.48B 37.49B 465B 37.19B 36.38B 1,600B
Net income 1.16B 1.44B 1.26B 1.07B 2.03B 137B 2.07B 13.86B 5.44B 67.56B 5.4B 5.28B 232B 1.4B 1.74B 1.52B 1.29B 2.46B 166B 2.5B 16.75B 6.58B 81.63B 6.52B 6.38B 281B
Net Debt 3.21B 3.98B 3.49B 2.97B 5.63B 380B 5.73B 38.41B 15.08B 187B 14.96B 14.64B 644B 2.92B 3.61B 3.16B 2.69B 5.11B 345B 5.2B 34.85B 13.68B 170B 13.57B 13.28B 584B
Logo Lonza Group AG
Lonza Group AG is one of the world leaders of the contract development and manufacturing of pharmaceutical and biotechnology products. Net sales break down by family of products and services as follows: - biologics and bio-pharmaceuticals (55.9%): microbiological fermentation products, mammalian cell-based bio-pharmaceuticals, monoclonal antibodies, therapeutic proteins, etc.; - synthesis products (24.7%): chemopharmaceutical products, bioconjugates, small molecules, active pharmaceutical ingredients, complex intermediates, etc.; - specialised therapeutic products (15.8%): cell and gene therapies, synthetic therapeutic nucleic acids, oligonucleotides, microbial biological products, etc.; - others (3.6%).
Employees
20,000
Date Price Change Volume
10/07/26 CHF 586.00 +0.58% 107,734
09/07/26 CHF 582.60 +1.68% 109,518
08/07/26 CHF 573.00 -0.24% 163,145
07/07/26 CHF 574.40 -1.03% 181,030
06/07/26 CHF 580.40 +1.08% 209,470
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
586.00CHF
Average target price
669.22CHF
Spread / Average Target
+14.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LONN Stock